Search All Funding News

Filter NIAID Funding News by year:
2025 | 2024 | 2023

173 Results

Know Your Timeline to Award If All Goes According to Plan

Funding News Edition: January 17, 2024

Knowing when NIAID will begin funding your project is essential—it’s necessary for hiring support staff or arranging subcontracts or even timing a renewal application.

Don’t Waste Your Time: Take an Extra Minute When Selecting NOFOs, Form Sets

Funding News Edition: December 4, 2024

We’ve now reached a stretch of time in which two form sets (i.e., FORMS-H and FORMS-I) and two versions of certain notices of funding opportunities (NOFOs) will be active simultaneously.

FORMS-I Transition: Setting Up Dominoes to Topple on January 25, 2025

Funding News Edition: April 17, 2024

NIH will transition to FORMS-I for application due dates on or after January 25, 2025, and also implement new policies and procedures that accompany the switch.

Addressing Common Misconceptions About NOSIs

Funding News Edition: May 1, 2024

NIH uses notices of special interest (NOSIs) to invite applications on high-priority and high-opportunity areas of science. NOSIs are designed to reduce administrative burden on NIH staff and grant applicants alike.

Where to Check in an Opportunity for the Earliest Start Date

Funding News Edition: June 5, 2024

Most notices of funding opportunities list the application due date, peer review date, Advisory Council round, and earliest project start date in the “Key Dates” section of Part 1. Overview Information.

Ease Educational Debt Through Loan Repayment Programs

Funding News Edition: August 7, 2024

To be eligible, you must be a doctoral-level clinician or researcher who’s committed to conducting NIH-qualified clinical research. If NIH approves your application, we will repay up to $50,000 each year toward your qualified educational debt.

News Briefs and Worth Repeating

Funding News Edition: October 2, 2024

Reminder of NIH Policy on Late Applications Caused by Weather Emergencies; Examine Data on Professional Degree Types in NIH’s Grant Portfolio; NIH Revises Its Definition of Sexual and Gender Minority Populations

Don’t Get Spooked—Check the Grant Number for Unfunded Notifications

Funding News Edition: October 16, 2024

If you or your institution receives a notification alerting you that a change was made to your application status, pay attention to the grant application number referenced in the message.

Competing Revisions and How They Differ from Administrative Supplements

Funding News Edition: April 3, 2024

A competing revision provides additional funding for activities that call for an expansion of your original scope of award, whereas administrative supplements fund activities that, while unforeseen when the application was being submitted, are still within the scope of the project.

Conduct Translational Exploratory Research on Chemical Countermeasures

Funding News Edition: November 20, 2024

Research civilian chemical medical countermeasures and novel treatment strategies to combat serious morbidity and mortality resulting from high consequence public health chemical emergencies.

Understand Clinical Trials to Choose the Right Funding Opportunity

Funding News Edition: February 21, 2024

NIH defines a clinical trial as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.

Develop Tools to Tackle Antibiotic-Resistant Gram-Negative Bacteria

Funding News Edition: May 15, 2024

This opportunity will support milestone-driven projects focused on developing novel predictive models, assays, tools, or platforms aimed at gaining a better understanding of the rules and compound properties that govern the penetration and efflux of drug-like small molecules into Gram-negative bacterial pathogens.

Request Funding to Explore Controlled Release of HIV Vaccines

Funding News Edition: May 1, 2024

Conduct product-focused research to advance controlled-release vaccine strategies shown to improve immune responses for HIV prevention, treatment, and cure, and also to develop simplified or single-shot vaccination formulations.

Explore Mechanisms of Adverse Health Effects on the Nervous System After Toxic Chemical Exposure

Funding News Edition: December 4, 2024

Propose research on the fundamental mechanisms of toxicity of highly toxic Chemicals of Concern but also on potential new targets to inform the development of medical countermeasures that would be effective during and after civilian mass exposure situations. 

Organize Meetings for the Chemical Countermeasures Research Program

Funding News Edition: October 2, 2024

Apply to organize a series of annual in-person scientific meetings, conferences, symposia, and workshops to advance innovations in therapeutic and chemical toxicology research.

For Ancillary Studies, Consider NIH Definitions Carefully

Funding News Edition: June 20, 2024

An ancillary study is an independent research project that uses samples or data from a parent study to extend knowledge in scientific areas beyond the original scope of the parent study. It may qualify as a clinical study or a clinical trial.

Develop Diagnostics, Therapeutics, and Vaccines for Herpes Simplex Virus

Funding News Edition: May 15, 2024

Apply if you can further the development of new products to prevent herpes simplex virus infection and improve the diagnosis and treatment of patients living with herpes.

Small Business Research: Priority Funding Topics for 2025

Funding News Edition: August 7, 2024

NIH assembled a list of scientific priorities for small business awards that match the research interests of its institutes and centers, including NIAID.

Help Develop Long-Acting and Simplified HIV Treatments

Funding News Edition: December 18, 2024

NIAID will support the development of safe and effective long-acting/sustained release technologies to help prevent and treat HIV and related co-infections such as tuberculosis, hepatitis B, and hepatitis C.

Request Support to Study Inborn Errors of Immunity

Funding News Edition: April 17, 2024

Research the causes and mechanisms of inborn errors of immunity, enable early detection and molecular diagnosis, and support strategies to treat and cure these disorders.

Improve Understanding of Mechanisms, Biomarkers of Trained Immunity

Funding News Edition: February 21, 2024

Apply for research support to study basic mechanisms and biomarkers of trained immunity (i.e., innate immune memory), plus the functional implications of trained immunity.

Act Now for Funding to Establish T32 Training Slots for Data Science

Funding News Edition: September 4, 2024

Predoctoral trainees should become capable of applying data science methods and technologies across infectious and immune-mediated diseases research domains.

Contact Us

Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.